Aims: To investigate the physiological mechanisms leading to rapid improvement in diabetes after Roux-en-Y gastric bypass (RYGB) and specifically the contribution of the concurrent perioperative dietary restrictions, which may also alter glucose metabolism.
| INTRODUCTION
Roux-en-Y gastric bypass (RYGB) surgery is one of the most effective surgical approaches to alleviate obesity and its major accompanying morbidity, type 2 diabetes mellitus (T2DM). 1, 2 Glucose levels improve within a few days post-RYGB, preceding substantial weight loss. [3] [4] [5] Much work is under way attempting to elucidate the weight lossindependent beneficial mechanisms of RYGB. One key topic of contention is whether the radical improvement observed in glucose homeostasis immediately after RYGB is determined by surgerymediated alterations in glucose metabolism or by the severe diet restrictions enforced in the peri-surgical period.
The biological mechanisms by which RYGB induces such a profound impact on glycaemia are far from understood. The role of ghrelin, the "hunger hormone", the effect of incretins such as gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1), the alterations in bile acid recirculation and changes in gut microbiota have all been implicated in the rapid glycaemic improvement after gastric bypass surgery. 3, 6, 7 It has long been known, however, that a very-low-calorie diet (<800-1000 kcal/d) in patients with T2DM has a significant positive impact on fasting and postprandial glucose levels as well as on β-cell function, insulin sensitivity, hepatic glucose output and ectopic fat deposition. [8] [9] [10] [11] [12] The immediate post-RYGB diet is very restrictive, starting with few calories in the first postoperative day and gradually increasing over the next few days. By the end of the first week postsurgery, most patients still consume <500 kcal/d. It is therefore reasonable to consider that at least some of the improvement in glycaemia observed in the days after RYGB is attributable to diet restriction. Studies that have evaluated the contribution of diet restriction in the immediate postoperative period had contradictory results, some concluding that the restricted diet mediates the noted effects, [13] [14] [15] [16] while others concluded that surgery-induced changes were driving this process. 17, 18 To further explore this controversy, we enrolled obese patients with T2DM in a study comparing the effects of a typical peri-operative diet in the absence of surgery with the effects of a matched diet administered in conjunction with RYGB in the same patients after a washout period of several months. 5 Our goal was to contrast the metabolic signature of the two interventions in order to expand our understanding of the mechanisms leading to glycaemic improvement after RYGB, so as to better understand the differential roles of diet vs surgically induced metabolic changes in T2DM resolution.
| MATERIALS AND METHODS

| Study population
We recruited adult patients diagnosed with T2DM and meeting criteria for RYGB from the Bariatric Surgery Clinic at University of Texas Southwestern (UTSW) Medical Center. Exclusion criteria included severe anaemia, chronic renal disease, problematic peripheral intravenous access, and treatment with incretin mimetics or dipeptidyl peptidase-4 inhibitors within 3 months before recruitment.
The UTSW institutional review board approved the study, and all patients signed informed consent before enrolment.
| Study design and protocol
The study design has been published previously. 5 The protocol comprised two identical 10-day rigorously overseen inpatient periods, separated by an average 3.3-month washout interval sufficient for the metabolic characteristics to return to their baseline values. During the first study period (diet-only period), patients followed the strict post-RYGB recommended diet, were treated with the same intravenous fluids, and observed the same activity restrictions recommended for patients who undergo the procedure. In the morning of days 2 and 10, after 12 hours overnight fasting, a 6-hour mixed-meal challenge test (MMCT) was performed, with blood sampling at 22 time points.
The total caloric intake (oral or intravenous; including caloriecontaining liquids, intravenous fluids and medications) for the period between the two MMCTs was~1700 kcal (total for 8 days), which is the customary intake for the first week post-RYGB. Total volume intake (oral plus intravenous) was~18 L for the entire period. During the washout period patients were advised to return to their usual lifestyle. The second study period (diet and RYGB period) was identical to the first study period, with the exception of day 3 when RYGB surgery was performed. During this period patients were pair-fed to their own daily oral intake during the first study period, were administered the same amount and type of intravenous fluids, and followed the same activity restrictions. The RYGB procedure was performed laparoscopically using a 25-mm EEA stapler to create a gastro-jejunal anastomosis and a linear 60-mm stapler to create a jejuno-jejunal anastomosis. 19 The length of the Roux limb was 100 cm. No surgery-related complications were observed. The 6-hour MMCT was repeated on the same days 2 and 10 as in the preceding period (overall a total of four tests per patient). All oral anti-diabetic medications were withheld starting 3 days before, and all subcutaneous insulins were withheld 24 hours before each study period. During the active study periods patients were treated only with intravenous boluses of regular insulin if capillary glucose readings were > 11 mmol/L. No insulin was administered within 10 hours of each MMCT. No other glucose-lowering agents were administered during the active study periods. We report the fasting, mean and area under the curve (AUC) values. Total AUC was computed using the trapezoidal rule.
| Measurements
We estimated insulin resistance/sensitivity using the corrected homeostatic model assessment of insulin resistance (HOMA2-IR) 20 and the Matsuda index (10 000 /[fasting plasma glucose × fasting plasma insulin × glucose mean0-360 × insulin mean0-360 ] 0.5 ). 21 Two additional insulin sensitivity indices were quantified using the oral glucose insulin sensitivity index 22 and Stumvoll's index. 23 β-cell function estimates were calculated using mathematical modelling analysis based on C-peptide deconvolution. 22, 24 This model provides calculation of β-cell glucose sensitivity (the slope of the insulin secretion-glucose concentration relationship), rate sensitivity (marker of early insulin release), and potentiation factor (described in detail by Mari et al
24
)
. Basal and stimulated insulin clearance were calculated from the ratio of insulin secretion AUC/insulin AUC. 25 Insulin secretion at 9 mmol/L glucose, and integral of total insulin secretion during the MMCT, were determined from the modelestimated β-cell dose response as previously described. 26 An empirical additional β-cell function index was estimated by the ratio between AUC for C-peptide and glucose. The disposition index was used to account for the correlation between insulin secretion and insulin sensitivity 27 and was determined by multiplying the insulin secretion (AUC C-peptide /AUC Glucose ) by the Matsuda index. 28 Fasting hepatic glucose production, glucose clearance, and the total rate of glucose appearance during the 6-hour MMCT were estimated using a previously described glucose kinetics model, 29 based on the deuterated glucose tracer method. 30 Labelled glucose was measured by isotope dilution with mass spectrometry as previously described. 31 Calibration curves were calculated from gravimetric mix- 30 The hepatic insulin resistance index was determined by multiplication of hepatic glucose production to basal insulin. Arbor, Michigan). Plasma adiponectin and leptin were measured using sandwich ELISA kits (Millipore). 3 | RESULTS
| Statistical analysis
| Baseline characteristics and weight change
As reported previously, 5 between periods]).
| Glycaemic variables
We previously reported that all measured glycaemic variables (daily capillary blood glucose readings, HbA1c, fasting plasma glucose, maximum glucose and glucose AUC) improved numerically in both study periods, but only the improvement during the diet period reached statistical significance (Table 1, Table S1 and Figure 1A ). 
| β-cell function
Estimates of all variables related to β-cell function and insulin sensitivity are presented in Table 1 . Fasting (basal) insulin and insulin AUC during the 6-hour MMCT did not change significantly in the diet-only period, but decreased in the diet and RYGB period (Table 1 and Figure 1B ). C-peptide AUC/glucose AUC increased during the dietonly period (P = .01) and did not change during the diet and RYGB period (P = .35; P = .02 between periods [ Table 1 and Figure 1D ]).
Glucose-stimulated insulin secretion was increased in the postdiet-only period and was unchanged after the diet and RYGB period (Table 1 and Figure S1 ). A similar pattern was observed for insulin secretion at 9 mmol/L glucose.
Insulin clearance improved during both periods, but the difference was statistically significant only after the diet and RYGB period, from 1.68 to 2.55 L/min/m 2 (P = .01), with a significant difference between periods (P = .03; Table 1 ).
| Insulin sensitivity
All indices of insulin resistance (HOMA2-IR) and sensitivity (Matsuda, Stumvoll, and 2-hour oral glucose insulin sensitivity) improved to a similar extent during each study period (Table 1) , as did the disposition index (Table 1) . 
Fasting (basal) hepatic glucose production decreased significantly after the diet-only period (P = .007), while it increased slightly after the diet and RYGB period (P = .55; P = .03 between periods [ Table 2 ]).
Appearance of oral glucose was delayed after the diet-only period by 5.17 minutes (P = .08) and was faster after diet and RYGB period by 10.61 minutes (P = .008; between periods P = .008 [ Table 2 ]).
Hepatic insulin resistance index improved numerically only and to a similar extent in both periods (Table 2 ). Table 3 summarizes the results of the hormone measurements (other than insulin and C-peptide, which are presented in Table 1 
| Hormonal changes
| Lipid metabolism
Changes in total, LDL and HDL cholesterol were not different between periods (Table S1 ). Triglyceride levels decreased during both study periods, but significantly more during the diet-only period (P = .04 between periods), while fasting and AUC for free fatty acids increased significantly only during the diet-only period (P = 0.01 between study periods [ Table S1 ]).
| DISCUSSION
In the present study we performed a very tightly controlled intervention to precisely evaluate and contrast the acute metabolic and hormonal changes which occur with a bariatric-like diet (diet-only period)
vs the same diet in the context of RYGB (diet and RYGB period). The goal was to evaluate the contribution of the severe dietary restriction imposed in the immediate postoperative period to the rapid improvement in glycaemia in obese patients with T2DM undergoing RYGB.
The main conclusion of the present study is that the austere caloric restriction employed immediately post-gastric bypass surgery is a main mediator of the acute improvement in glycaemia observed after RYGB. Both interventions improved β-cell function, insulin resistance, and hepatic glucose output, but interestingly several markers of β-cell function/insulin secretion, as well as fasting hepatic glucose production, improved significantly more during the diet-only period compared with the diet and RYGB period. Abbreviations: 2-h OGIS, oral glucose insulin sensitivity index (2-h equation); AUC, area under the curve, Clinsb, basal insulin clearance (basal insulin secretion/basal insulin); Clins, insulin clearance (insulin secretion AUC/insulin AUC); HOMA2-IR, homeostastic model of assessment of insulin resistance; ISR, insulin secretion rate (at 9.0 mmol/L glucose from the dose-response). Data represents least squares means (95% CI). The significance of the change within each period is presented in the column marked "P", the diet-only period and diet and RYGB period, respectively, whereas the significance of the change between periods is shown in the column marked "Between periods P". were our reported results and conclusions. Lastly, the type of metabolic assessments employed could also have influenced the outcomes.
We chose a standardized oral mixed-meal stimulus over an intravenous stimuli or glucose-only stimuli as it most closely mimics the real-life physiological stimuli for these patients and thus allowed us to evaluate their metabolism in a close to real-life setting. We also extended the MMCT to 6 hours, uniquely amongst all these studies, to capture the full postprandial dynamic profile of glucose and hormonal excursions. Abbreviations: EGP-IR, endogenous glucose production × basal insulin (hepatic insulin resistance index); MMCT, mixed meal challenge test. Data represent least squares means (95% CI). The significance of the change within each period is presented in the column marked "P", the diet-only period and diet and RYGB period, respectively, whereas the significance of the change between periods is shown in the column marked "Between periods P". 3-h mean glucose appearance time: integral of time × rate of appearance in the first 3 h of the MMCT divided by the integral of the rate of appearance over the same interval. 
We, and other investigators, 36,37 noted significant increases in the peak postprandial GLP-1 and PYY after surgery, but not after the diet-only period. The postoperative surge in these hormones is thought to be attributble to the delivery of undigested, highly concentrated food content directly to the hindgut, where it stimulates the secretion of these hormones with known anti-diabetes effect. 38 While it is very tempting to claim a causative effect between the rapid improvement in glycaemia and the significant postoperative rise of these known anti-diabetogenic hormones, our findings suggest that this relationship may just be an association. Other investigators have made similar observations when they reported that GLP-1-deficient mice retain the positive effects of RYGB in glycaemia improvement. 39 The present study has several limitations. We used a single tracer to avoid further complicating an already complex protocol. The sample size of 10 completers was relatively small, although is comparable to other similarly detailed mechanistic studies. Lastly, it was not possible to randomize the order of the two interventions and therefore we cannot exclude a possible carryover effect from the first intervention to the second. Despite a long washout period (average 101.6 days), weight did not return to baseline (143.2 vs 138.6 kg) and some metabolic variables were numerically (but not statistically) different (Table S2 ). While this difference between the baseline metabolic status might have minimized the effect of the second intervention, it is notable that all measured glycaemic indices post-RYGB were still above normal and, as such, opportunity for further improvement was present.
In conclusion, the present study shows that the improvements in the glycaemic variables, insulin sensitivity, β-cell function, and hepatic glucose production (well described after RYGB) are primarily mediated by the very restricted peri-operative diet as these changes were also observed (some with even greater magnitude) when a matched peri-operative diet was consumed in the absence of surgery. Surgery induced dramatic increases in postprandial GLP-1 and PYY, but these do not appear to improve glycaemia, insulin resistance or β-cell function beyond the effects observed with the equivalent dietary restriction alone. Abbreviations: AUC, area under the curve; GIP, gastric inhibitory polypeptide; GLP-1, glucagon like peptide 1; PYY, peptide YY; FGF, fibroblast growth factor. Data represent least squares means (95% CI). The significance of the change within each period is presented in the column marked "P", the diet-only period and diet and RYGB period, respectively, whereas the significance of the change between periods is shown in the column marked "Between periods P". 
